Dublin, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/gk23nq/molecular) has announced the addition of the "Molecular Diagnostic Testing for Infectious Diseases Global Market Size, Strategies and Forecasts 2016 to 2020 " report to their offering.
The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing. Infectious disease testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report. A range of dynamic trends are pushing market growth and company valuations.
Trends like:
- changing demographics
- emerging economies and global prosperity
- biotechnology advances in genetics
- pathogen evolution
- climate change
- globalization
- automation
Exciting technical developments especially in the area of molecular diagnostics and pharmacogenics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.
The report has hundreds of pages of information including a complete list of Current 2016 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.
The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
This research makes you the expert in your organization.
All report data is available in Excel format on request.
Make investment decisions and valuations with confidence using the latest data.
Key Topics Covered:
1. Introduction and Market Definition
2. The Infectious Diseases - Market Analysis by Disease
3. Industry Overview
4. Market Trends
5. Molecular Dx - Infectious Disease Recent Developments
6. Country Market Sizes - North America
7. Country Markets - Europe
8. Country Markets - Asia Pacific
9. Country Markets - Latin America, Africa & The Middle East
10. Global Market Summary
Companies Mentioned
- Abbott Laboratories
- Agendia
- Agilent/Dako
- Becton, Dickinson & Co.
- bioMérieux
- Cepheid
- Foundation Medicine
- Genomic Health
- Grifols
- Hologic
- Illumina
- Myriad Genetics
- Qiagen
- Roche Molecular Diagnostics
- Siemens Healthcare
- Signal Genetics LLC
- Thermo Fisher
For more information visit http://www.researchandmarkets.com/research/gk23nq/molecular
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, In Vitro Diagnostics, Infectious Disease Testing, Molecular Diagnostics


Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 



